From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.68
First Reported 2007
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 2
Total Number 2
Disease Relevance 0.34
Pain Relevance 0.28

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

endosome (PTPRF) cell adhesion (PTPRF) plasma membrane (PTPRF)
PTPRF (Homo sapiens)
Pain Link Frequency Relevance Heat
Parenteral administration 2 93.00 High High
agonist 16 89.40 High High
Dopamine 13 89.08 High High
Somatostatin 3 50.00 Quite Low
imagery 7 30.48 Quite Low
tolerance 6 5.00 Very Low Very Low Very Low
Bioavailability 3 5.00 Very Low Very Low Very Low
nud 2 5.00 Very Low Very Low Very Low
cytokine 2 5.00 Very Low Very Low Very Low
antagonist 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Hypoglycemia 23 78.72 Quite High
Galactorrhea 3 75.16 Quite High
Diabetes Mellitus 84 69.84 Quite High
Obesity 12 51.28 Quite High
Cancer 14 50.00 Quite Low
Pituitary Cancer 5 50.00 Quite Low
Empty Sella Syndrome 5 34.16 Quite Low
Acromegaly 10 12.04 Low Low
Pituitary Apoplexy 1 6.48 Low Low
Vomiting 25 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
For the patients treated with slow-release formulations of SSTa (Somatuline Autogel, Octreotide LAR), the hormonal assessment was carried out on the day before the injection.
Localization (release) of LAR
1) Confidence 0.68 Published 2007 Journal Clinical Endocrinology Section Body Doc Link PMC1974833 Disease Relevance 0.08 Pain Relevance 0.24
Long-acting release preparation of EX (EX LAR) is currently in the phase of clinical development.
Localization (release) of LAR
2) Confidence 0.17 Published 2010 Journal Indian Journal of Pharmaceutical Sciences Section Body Doc Link PMC2883206 Disease Relevance 0.27 Pain Relevance 0.05

General Comments

This test has worked.

Personal tools